ArticleEuropean journal of clinical pharmacology2021

Doctor's aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center.

Omar Al Tabaa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.